A Positive Modifier of Spinal Muscular Atrophy in the SMN2 Gene
Top Cited Papers
- 11 September 2009
- journal article
- case report
- Published by Elsevier BV in American Journal of Human Genetics
- Vol. 85 (3), 408-413
- https://doi.org/10.1016/j.ajhg.2009.08.002
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Child Health and Human Development
- National Center for Research Resources
- National Institutes of Health (R01-HD054599-01)
- National Institute of General Medical Sciences (C06-RR11234, UL1-RR025764)
This publication has 29 references indexed in Scilit:
- Phase II Open Label Study of Valproic Acid in Spinal Muscular AtrophyPLOS ONE, 2009
- Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2American Journal of Medical Genetics Part A, 2004
- ESEfinder: a web resource to identify exonic splicing enhancersNucleic Acids Research, 2003
- A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophyNature Genetics, 2003
- Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1Nature Genetics, 2002
- Quantitative Analyses of SMN1 and SMN2 Based on Real-Time LightCycler PCR: Fast and Highly Reliable Carrier Testing and Prediction of Severity of Spinal Muscular AtrophyAmerican Journal of Human Genetics, 2002
- Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2Genetics in Medicine, 2002
- Animal models of spinal muscular atrophyHuman Molecular Genetics, 2000
- Htra2-β 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 ( SMN2 )Proceedings of the National Academy of Sciences of the United States of America, 2000
- An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMNHuman Molecular Genetics, 2000